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Introduction
Functional quantification by using strain and strain rate through 
speckle tracking echocardiography has been developed as a 
promising tool in recent clinical situations.1-3) The recent introduction 
of two-dimensional (2D) strain and strain rate imaging by using the 
speckle tracking method for an accurate assessment of global and 
regional myocardial function has been studied for use in a variety of 
clinical settings.4-8) However, the use of these tools in right ventricle 
(RV) failure and the manner in which they both reflect the functional 
capacity of patients have not yet been studied thoroughly, although 
the importance of RV in the management and prognosis of many 
cardiac diseases–such as congestive heart failure, arrhythmia, and 
sudden cardiac death-is increasingly being recognized.9)10) In the 
present study, we assess the changes in RV function due to continuous 
RV volume overload in patients with atrial septal defects (ASDs) on 
the basis of strain and strain rate. Likewise, we analyze the correlation 
between the changes in strain and strain rate in patients at 1 month 
after transcatheter closure of ASD in the process of recovery from 
right heart failure and the changes in exercise capacity as measured 
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with the cardiopulmonary exercise test (CPET). By doing so, we expect 
to gather objective information about both the role of strain and strain 
rate in the assessment of RV function, and the changes in exercise 
capacity due to the changes in strain and strain rate in the process 
of RV reverse modeling.11-13) Therefore, the aim of our study was to 
investigate the change in exercise capacity and strain pattern before 
transcatheter closure of ASD and at 1 month after the procedure.
Subjects and Methods
Patients
A total of 30 patients who underwent transcatheter closure of ASD 
between May 2014 and June 2015 at our institution were enrolled. All 
patients consented to an agreement approved by the institutional 
review board of the Human Research Protection Center of the 
Severance Hospital Yonsei University Health System (IRB no. 2013-
0104-001). Twenty-one patients were included in the ‘improved’ 
group, which was defined as patients with improved exercise 
capacity before and after the procedure; and nine patients were 
included in the ‘non-improved’ group, which was defined as patients 
with decreased or unchanged exercise capacity before and after 
the procedure (Fig. 1). We excluded all patients who concurrently 
had pulmonary hypertension at the time of diagnosis (which was 
defined as a mean pulmonary arterial pressure of ≥25 mmHg on 
cardiac catheterization), as well as those who did not want to 
continue with the study after 1 month.
Transthoracic echocardiography
All examinations were performed with subjects in the supine 
position, using a GE E9 machine (Vivid 9; GE Medical Systems, 
Milwaukee, WI, USA). To minimize inter-observer and intra-observer 
variations, one well-trained person performed all examinations. 
Strain and torsion were calculated from the obtained 2D 
echocardiographic data by using the EchoPAC system software (GE 
Medical Systems, Milwaukee, WI, USA). The global RV longitudinal 
(GRVL) strain, obtained through a full RV myocardium method, was 
calculated on the basis of the entire trace contour of the RV via 
apical four-chamber view 2D echocardiography (Fig. 2). Moreover, 
LV torsion was determined from the parasternal short-axis view of 
the 2D echocardiogram at the mitral valve (basal) and apical  levels 
(Fig. 3). To minimize inter-observer and intra-observer variations, 
semi-automatic endocardial border tissue tracing was performed 
at an average of three times per study.
Laboratory test
In all patients, venous blood samples were collected before the 
procedure and at 1 month after the procedure. N-terminal pro-
Fig. 1. Individual exercise capacity changed in each group. The improved group was defined as patients with improved exercise capacity before and after 
the procedure. The non-improved group was defined as patients with decreased or unchanged exercise capacity before and after the procedure. 
Fig. 2. Longitudinal strain of the right ventricle, in the four-chamber 
view. (A) Two-dimensional image of the four-chamber view. (B) Right 
ventricle strain on the speckle tracking image, semi-automatically divided 
into six segments (basal, mid, and apical segments of the septum and 
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brain natriuretic peptide (NT-proBNP) and mean platelet volume 
(MPV) were also measured in this study.14)15)
Cardiopulmonary exercise test
All patients carried out a maximal, symptom-limited (fatigue 
or dyspnea) CPET by using the Bruce ramp protocol.16) Patients 
were encouraged to continue with the exercise for as long as 
they could. The maximal oxygen consumption (VO2max), carbon 
dioxide production (VCO2), minute ventilation (VE), work load, 
lactate threshold (LT), and age-predicted exercise capacity (APEC) 
were measured by using breath-by-breath gas analysis. A standard 
12-lead electrocardiogram was continuously recorded. Blood 
pressure was measured with a cuff sphygmomanometer. VO2max 
was defined as the amount of oxygen consumed by the body at 
the peak of tolerable exercise. VE/VCO2 was defined as ventilator 
efficiency. The LT was defined as the point at which oxygen 
delivery to the muscles failed to meet 100% of demand, requiring 
anaerobic metabolism to supplement the energy requirements. The 
initial phase of CPET lasts until 50-60% of VO2max is reached. VE 
increases linearly with VO2 and reflects aerobically produced CO2 
in muscles. The blood lactate levels do not change during this 
phase. During the latter half of the exercise, anaerobic metabolism 
occurs because the oxygen supply cannot meet the increasing 
metabolic demands of the exercising muscles. At this time, there 
is a significant increase in lactate production in the muscle and in 
blood lactate concentration. The VO2 at the onset of blood lactate 
accumulation is called the LT. All patients underwent CPET before 
the procedure and at 1 month after the procedure, each according 
to protocol.
Statistical analysis
Statistical analysis was performed by using SAS (version 9.3; 
SAS Inc., Cary, NC, USA). Continuous values are reported as 
mean±standard deviation. The Shapiro-Wilk test was used to 
check for normality of distribution. If the data followed a normal 
distribution, a paired t-test was used to compare the differences in 
parameters before the closure and 1 month after the procedure, 
and the independent t-test was used to compare the differences 
between the improved and non-improved groups. If the data did 
not follow a normal distribution, the Wilcoxon signed-rank test was 
used to compare the differences in parameters before the closure 
and 1 month after the procedure, and the Mann-Whitney U-test 
was used to compare the differences between the improved and 
non-improved groups. The comparisons of differences between 
before and after the procedure in each group were analyzed by 
using a linear mixed model. A p value was obtained from Fisher’s 
exact test. Differences were considered to be statistically significant 
when the p value was <0.05.
Results
Baseline patient characteristics
Transcatheter ASD closure with the Amplatzer septal occluder 
(AGA Medical Corporation, Golden Valley, MN, USA) device was 
successfully performed for all patients. The patient characteristics 
Fig. 3. LV torsion. (A) Parasternal short axis view, 
mitral level. (B) Parasternal short axis view, apical level. 
(C) LV torsion was obtained from (A) and (B), and 
calculated by using the EchoPAC system (GE Medical 
Systems, Milwaukee, WI, USA). LV: left ventricle.
A  C
B
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are presented in Table 1. Their mean age was 34.5±12.1 years (range, 
15-55 years), and the male-to-female ratio was 1:2. The peak RV 
pressure (pRVP) was 36.6±10.8 mmHg, and the mean ratio of 
pulmonary to systemic blood flow (Qp/Qs) was 2.1±0.5. The mean 
size of the implanted device was 22.3±4.9 mm. There was no 
mortality; and there were no major complications such as device 
embolization, cardiac tamponade, life-threatening arrhythmias, or 
vascular complications requiring surgery. After 1 month of follow-
up, there was no residual shunt.
Parameters before and after the procedure
All patient results before and after ASD closure are provided in 
Table 2. In CPET, the VO2max. (27.0±4.5 to 31.3±6.9 mL·kg
-1·min-1, 
p<0.0001), metabolic equivalents (METs) (7.7±1.2 to 8.7±1.8 METs, 
p<0.0001), and APEC (72.0±20.6% to 78.7±20.1%, p=0.0013) were 
significantly improved after ASD closure. NT-proBNP (87.9±55.9 
to 118.3±91.3 pg/mL, p=0.0071) and MPV (8.0±0.7 to 9.0±1.4 fL, 
p=0.0067) were both significantly increased after ASD closure. In the 
strain parameters, LV torsion was increased significantly (10.4±2.3°/ms 
to 12.7±3.0°/ms, p=0.001). GRVL strain was decreased; however, the 
difference was not statistically significant (p=0.0528). The VE/VCO2 
slope was not significantly changed.
Comparison between the improved and non-improved 
groups in CPET
To find the correlation between CPET results and strain, the 
patients were divided into an ‘improved’ group (n=21) with 
increased VO2max and a ‘non-improved’ group (n=9) with 
unchanged or decreased VO2max. Fig. 1 shows the changes in 
individual exercise capacity within each group. The sex composition 
and age, Qp/Qs, and RV pressure (RVP) were similar between the 
two groups. However, the device size was significantly greater in 
the improved group (23.7±4.8 vs. 19.0±3.5 mm, p=0.014) (Table 3). 
In the comparison of differences in CPET between the two groups 
before the closure and 1 month after the procedure, APEC was 
significantly higher in the improved group (78.2±20.5% vs. 57.7±12.6%, 
p=0.0099) before the procedure, and the other parameters except for 
VE/VCO2 were increased significantly in the improved group after the 
procedure (Table 4).
Comparison of NT-proBNP and MPV between the improved 
and non-improved groups before and after the procedure
NT-proBNP was significantly higher in the non-improved group 
than in the improved group before closure (35-100 vs. 82-211 pg/mL, 
p=0.0087) and at 1 month after the procedure (31-85 vs. 131-305 
pg/mL, p=0.0004) (Table 5), (Fig. 4). In the comparison of each group 
before the closure and 1 month after the procedure, NT-proBNP was 
only increased significantly post-procedure in the non-improved 
group (p<0.0001) (Table 5). MPV showed no difference between the 
two groups (p=0.1457) before the procedure, but it was significantly 
larger in the improved group (8.1–10.3 vs. 7.1–9.6 fL, p=0.0174) at 1 
month after the procedure (Table 6). In the comparison of each group 
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Table 2. Parameters measured before and after transcatheter closure of atrial septal defects
Parameters Pre-procedure Post-procedure p
CPET VO2max (mL·kg
-1·min-1) 27.0±4.5 31.3±6.9 <0.0001
Work load (METs) 7.7±1.2 8.7±1.8 <0.0001
APEC (%) 72.0±20.6 78.7±20.1 0.0013
LT (mL·kg-1·min-1) 19.7±3.4 21.5±4.5 0.1279
VE/VCO2* 29.3±5.2 29.1±5.1 0.6856
Lab NT-proBNP (pg/mL) 87.9±55.9 118.3±91.3 0.0071
MPV (fL) 8.0±0.7 9.0±1.4 0.0067
Strain LV torsion (°/ms) 10.4±2.3 12.7±3.0 0.001
GRVL strain (%/ms) -21.3 (-24.2 to -17.9) -18.8 (-24.1 to -15.8) 0.0528
Values are presented as mean±standard deviation. *VE/VCO2: <30: normal, >60: suspected severe cardiopulmonary disease. CPET: cardiopulmonary exercise 
capacity test, METs: metabolic equivalents, APEC: age-predicted exercise capacity, LT: lactate threshold, VE/VCO2: minute ventilation/carbon dioxide produc-
tion, NT-proBNP: N-terminal brain natriuretic peptide, MPV: mean platelet volume
Table 3. Comparison of characteristics between the improved and non-improved groups 
Characteristics Total Improved (n=21) Non-improved (n=9) p
Sex >0.999*
Male 10 7 3
Female 20 14 5
Age (years) 34.5±12.1 34.6±11.4 34.2±14.3 0.9436
Device size (mm) 22.3±4.9 23.7±4.8 19.0±3.5 0.0140
Qp/Qs 2.1 (1.8-2.3) 1.9 (1.7-2.2) 2.2 (2.0-2.4) 0.0932
RVP (mmHg) 32 (30-40) 31 (30-40) 35 (31-45) 0.3132
Values are presented as mean±standard deviation. *The p value is from Fisher’s exact test. Qp/Qs: ratio of pulmonary to systemic flow
Table 4. Comparisons of CPET between the improved and non-improved groups before and after the procedure 
Improved (n=21) Non-improved (n=9) p
Pre
VO2max (mL·kg
-1·min-1) 27.7±4.2 25.4±4.9 0.1876
Work load (METs) 7.87±1.1 7.24±1.3 0.1841
APEC (%) 76 (60–100) 52 (48–71) 0.0067
LT (mL·kg-1·min-1) 19.7 (17.4–20.5) 20.3 (16.4–26.8) 0.4972
VE/VCO2 26.3 (25.3–31) 29.3 (27.9–31.6) 0.0573
Post 
VO2max (mL·kg
-1·min-1) 34.2±5.5 24.6±4.9 0.0001
Work load (METs) 9.43±1.4 6.9±1.4 0.0001
APEC (%) 89 (81–100) 52 (43–75) 0.0003
LT (mL·kg-1·min-1) 23.6±3.2 16.7±3.3 <0.0001
VE/VCO2 26.8 (24.8–35.2) 27.5 (27.1–27.6) 0.7004
Values are presented as mean±standard deviation. CPET: cardiopulmonary exercise capacity test, VO2max: maximal oxygen consumption, METs: metabolic 
equivalents, APEC: age-predicted exercise capacity, LT: lactate threshold, VE/VCO2: minute ventilation/carbon dioxide production
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between before the closure and 1 month after the procedure, MPV 
was significantly larger post-procedure than pre-procedure in the 
improved group (p=0.0001), and was not significantly different at 
pre-procedure and post-procedure in the non-improved group 
(p=0.4837) (Table 6).
Comparison of the strain pattern between the improved and 
non-improved groups before and after the procedure
LV torsion was significantly higher in the non-improved group 
(12.2±1.9°/ms vs. 9.7±2.1°/ms, p=0.0046) (Table 7). LV torsion was 
significantly increased post-procedure (13.5±3.0°/ms vs. 9.7±2.1°/ms, 
p<0.0001) in the improved group, but was decreased post-procedure 
(10.8±2.3°/ms vs. 12.2±1.9°/ms) in the non-improved group, with no 
statistical significance (p=0.0911) (Table 7), (Fig. 4). Although there 
was no significant difference in GRVL strain between the improved 
and non-improved groups at pre-procedure and post-procedure 
(p=0.1295, p=0.1132), a tendency toward a decrease post-procedure 
(-18.1 [-20.8 to -15.8]%/ms) as compared with pre-procedure 
(-21.6 [-24.2 to -20.3]%/ms) was observed in the improved group, 
as well as an increase post-procedure (-27.2 [-28.0 to -16.4]%/ms) 
as compared with pre-procedure (-17.5 [-23.8 to -17.3]%/ms) in the 
non-improved group (Table 7).
Discussion
For decades, echocardiographic methods have been developed 
to accurately evaluate heart function in various cardiovascular 
diseases. Conventional echocardiography, which is focused on the 
subjective functional assessment of ventricles through “eyeballing” 
2D clips, is still the most frequently used technique in routine 
clinical settings.17) Although conventional echocardiography is 
considered to be reliable for the assessment of heart function, the 
visual assessment of wall motion and thickening for the estimation 
of heart function is very subjective and is highly dependent 
on the operator. It is also subject to inter-observer and intra-
Table 6. Comparison of MPV between the improved and non-improved groups before and after the procedure
Total Improved (n=21) Non-improved (n=9) p
MPV (fL)*
Pre 8 (7.5–8.3) 7.9 (7.5–8.1) 8.3 (7.6–9.5) 0.1457
Post 9.6 (7.4–10.1) 9.7 (8.1–10.3) 7.3 (7.1–9.6) 0.0174
p value 0.0067 0.0001 0.4837
*Reference range=7.4-12.1 fL. MPV: mean platelet volume
Table 7. Comparison of LV torsion and GRVL strain between the improved and non-improved groups before and after the procedure
Total Improved (n=21) Non-improved (n=9) p
LV torsion
Pre 10.4±2.4 9.7±2.1 12.2±1.9 0.0046
Post 12.7±3.1 13.5±3.0 10.8±2.3 0.0208
p value 0.001 <0.0001 0.0911
GRVL strain 
Pre -21.3 (-24.2 to -17.9) -21.6 (-24.2 to -20.3) -17.5 (-23.8 to -17.3) 0.1295
Post -18.8 (-24.1 to -15.8) -18.1 (-20.8 to -15.8) -27.2 (-28.0 to -16.4) 0.1132
Values are presented as mean±standard deviation. LV: left ventricle, GRVL: global right ventricular longitudinal strain
Table 5. Comparison of NT-proBNP between the improved and non-improved groups 
NT-proBNP (pg/mL)* Total Improved (n=21) Non-improved (n=9) p
Pre 73.5 (55–121) 65 (35–110) 87 (82–211) 0.0087
Post 85 (35–195) 81 (31–85) 195 (131–305) 0.0004
p value 0.0071 0.4527 <0.0001
*Reference range=0-88 pg/mL. NT-proBNP: N-terminal pro-brain natriuretic peptide
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observer variabilities, and allows for only a limited assessment of 
radial displacement and deformation, without the possibility of 
evaluating myocardial shortening and twisting. These limitations 
may be overcome through the measurement of regional myocardial 
deformation parameters with strain and strain rate. Few clinical 
studies have demonstrated the usefulness of the evaluation of 
myocardial function by using strain and strain rate in children and 
adults; however, the obtained information remains insufficient.18) 
According to a few studies, GRVL strain seemed to be a sensible 
and stable indicator of RV function (dependent on loading 
conditions). Therefore, our study aimed to prove the usefulness of 
the assessment of RV function by using strain and its correlation 
with exercise capacity and echocardiographic parameters.
Although the size of the defect in the improved group was large, 
the pre-procedure NT-proBNP and MPV levels were lower than in the 
non-improved group, and only APEC was high in the CPET. Moreover, 
the lower LV torsion and higher GRVL strain in the non-improved 
group pre-procedure was believed to be due to the difference in 
the right-side volume overload caused by the left to right shunt, 
affected by the difference in defect sizes. Although our study 
excluded patients with pulmonary hypertension, Nagaya et al.19)20) 
reported that the existence of pulmonary hypertension in patients 
with increased NT-proBNP was important, and that the NT-
proBNP level was higher with pressure overload than with volume 
overload. Kaya et al.14) reported that MPV, an indicator of platelet 
activation, was significantly higher and correlated with pulmonary 
hypertension in patients with ASD, and may also be used as an 
adjunctive diagnostic tool in diagnostic pulmonary hypertension. 
The change of MPV was not significantly correlated with the results 
of both groups because our study (as mentioned above) excluded 
patients with pulmonary hypertension. Likely, the change of MPV 
with each group from before to after the procedure was considered 
to be the result of hemodynamic changes due to the rapidly-
decreased RV volume/mass ratio after the procedure. On the basis 
of the normalization of the RV volume after ASD device closure, it 
may be considered that the decreased range of RV motion resulted 
in decreased GRVL strain.
Furthermore, Gorcsan and Suffoletto8) explained the decreased 
exercise capacity shown in CPET in ASD patients. In this study, 
although there was no difference in RVP or Qp/Qs between the two 
groups, the changes in the NT-proBNP level between pre-procedure 
and post-procedure were more apparent in the non-improved 
group than in the improved group, In addition, considering the 
difference in APEC as shown in CPET before the procedure-and 
considering the fact that the VE/VCO2 slope was more shallow in 
the improved group than in the non-improved group both before 
and after the procedure (although not statically significant, as the 
pRVP in the two groups were in the reference range)-the possible 
risks of pulmonary hypertension had caused the change in the level 
of exercise capacity. 
Along with the change in the NT-proBNP level after the 
procedure, LV torsion was decreased in the non-improved group, 
whereas it was increased in the improved group. As a result, the 
levels were lower in the improved group than in the non-improved 
group. This result significantly correlates with the change in the NT-
proBNP level and the improvement of exercise capacity in patients 
with ASD device closure in our study. According to Dong et al.,21) 
and Wu et al.,22) early LV dysfunction occurred after defect closure 
and the shutdown of the left-right (L-R) shunt, which was shown 
to be more significant in the non-improved group. According to 
Giardini et al.,23) this implied that before defect closure, a high 
volume overload was applied to the RV owing to the difference 
in the L-R shunt amount, which was affected by the difference in 
the defect size. Moreover, after the procedure and closure of the 
shunt, the preload applied by the volume overload was removed; 
however, the increase in left atrial pressure due to the increase 
in pulmonary vein pressure, and thus the increase in pulmonary 
artery pressure, increased the RV afterload in sequence, leading 
to the consequence. After the procedure and the shutdown of the 
L-R shunt, the under-loaded LV underwent reverse remodeling 
owing to increased LV volume and cardiac output. The GRVL strain 
was decreased in all patients after the procedure in our study. It 
was definitely decreased in the improved group as compared with 
the non-improved group after the procedure. This decrease was 
believed to be a process of reverse remodeling of the RV while 
reducing the RV volume overload after the procedure. On the other 
hand, the GRVL strain of the non-improved group was significantly 
increased after the procedure, showing that the reverse remodeling 
of the RV was insufficient after the procedure. Therefore, the 
increased GRVL strain was highly correlated with the decreased 
or unchanged exercise capacity in the non-improved group. NT-
proBNP was significantly higher in dilated cardiomyopathy or heart 
failure, and it correlated with LV stretch.24) Our study showed that 
NT-proBNP was significantly increased according to the normalized 
under-loaded LV after the procedure. Accordingly, the increase in LV 
torsion was strongly correlated with increasing exercise capacity. 
Therefore, the increased exercise capacity after ASD device closure 
strongly correlated with the change in GRVL strain, LV torsion, and 
NT-proBNP.
This study has some limitations. The overall patient number was 
small, and the follow-up period was short. However, its strength 
lies in showing that RV remodeling and the differences in several 
parameters before and after transcatheter closure of ASD was the 
main cause of the short-term difference in exercise capacity after 
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the procedure. Furthermore, along with additional data collection-
and the use of pulmonary vascular resistance or CPET data other 
than RVP, NT-proBNP, MPV, LV torsion, and GRVL strain-a scoring 
system should be invented to estimate the prognosis of the exercise 
capacity or the level of heart failure in patients after the closure of 
a large ASD. 
Conclusion
This study showed that patients recovered their exercise capacity 
after the transcatheter closure of ASD. The recovery of exercise 
capacity showed that this correlated with the degree of decreased 
GRVL strain and the degree of increased NT-proBNP and LV torsion 
before and after the procedure. Through this correlation, the 
above-mentioned parameters are expected to be useful prognostic 
factors for recovery of exercise capacity in patients with ASD device 
closure. Larger studies are needed to prove the reproducibility 
of strain and the feasibility of its use as a practical tool for the 
assessment of RV function in routine clinical settings.
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